ID

24973

Descripción

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Palabras clave

Versiones (1)
  1. 23/8/17 23/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

23 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION SAE continued NCT00291876

Inglés

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION SAE continued NCT00291876

1 formularios  
Study administration
Descripción

Study administration

Subject Number
Descripción

Subject Identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Study vaccine Information
Descripción

Study vaccine Information

Vaccine
Descripción

(specify mixed or separate)

Tipo de datos

text

Alias
UMLS CUI [1]
C0042210
Dose No
Descripción

Dose Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1115464
UMLS CUI [1,2]
C0042210
UMLS CUI [1,3]
C1519255
Lot No
Descripción

Lot Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2826710
UMLS CUI [1,2]
C0042210
Route / Site
Descripción

Administration Route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0042210
Date
Descripción

administration date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1533734
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0042210
Concomitant medication / vaccination that could have contributed to this SAE
Descripción

Concomitant medication / vaccination that could have contributed to this SAE

Drug / vaccine
Descripción

concomitant medication

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
Dosage
Descripción

Dosage

Tipo de datos

text

Alias
UMLS CUI [1]
C0178602
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Start Date
Descripción

concomitant medication start date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826734
End Date
Descripción

concomitant medication end date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826744
Relevant intercurrent illness & medical history that could have contributed to this SAE
Descripción

Relevant intercurrent illness & medical history that could have contributed to this SAE

Condition
Descripción

Condition

Tipo de datos

text

Alias
UMLS CUI [1]
C0012634
Still present?
Descripción

Condition still present

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C1519255
Drug(s) used to treat this SAE
Descripción

Drug(s) used to treat this SAE

Drug
Descripción

Drug

Tipo de datos

text

Alias
UMLS CUI [1]
C0013227
Dosage
Descripción

Dosage

Tipo de datos

text

Alias
UMLS CUI [1]
C0178602
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Start date
Descripción

drug start date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
End Date
Descripción

drug end date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Surgical treatment for this SAE
Descripción

Surgical treatment for this SAE

Surgical treatment for this SAE, please specify
Descripción

Surgical treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C1519255
Description
Descripción

Description

Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
Descripción

Description

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1519255
AEGIS number
Descripción

AEGIS number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0600091
Comments
Descripción

Comments

Comments
Descripción

Comments

Tipo de datos

text

Alias
UMLS CUI [1]
C0947611
Volver a la parte superior de la página

Similar models

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION SAE continued NCT00291876

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Study vaccine Information
Vaccine
Item
Vaccine
text
C0042210 (UMLS CUI [1])
Dose Number
Item
Dose No
integer
C1115464 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Lot Number
Item
Lot No
integer
C2826710 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Administration Route
Item
Route / Site
text
C0013153 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
administration date
Item
Date
date
C1533734 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Item Group
Concomitant medication / vaccination that could have contributed to this SAE
concomitant medication
Item
Drug / vaccine
text
C2347852 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
concomitant medication start date
Item
Start Date
date
C2826734 (UMLS CUI [1])
concomitant medication end date
Item
End Date
date
C2826744 (UMLS CUI [1])
Item Group
Relevant intercurrent illness & medical history that could have contributed to this SAE
Condition
Item
Condition
text
C0012634 (UMLS CUI [1])
Condition still present
Item
Still present?
boolean
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item Group
Drug(s) used to treat this SAE
Drug
Item
Drug
text
C0013227 (UMLS CUI [1])
Dosage
Item
Dosage
text
C0178602 (UMLS CUI [1])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
drug start date
Item
Start date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
drug end date
Item
End Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Surgical treatment for this SAE
Surgical treatment
Item
Surgical treatment for this SAE, please specify
text
C0543467 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Description
Description
Item
Description (provide a brief narrative description of the SAE including relevant diagnostic findings, lab data & evolution of the events etc…)
text
C0678257 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
AEGIS number
Item
AEGIS number
text
C0237753 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Comments
Comments
Item
Comments
text
C0947611 (UMLS CUI [1])
Volver a la parte superior de la página 

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial